N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003
Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension Source: Eur Respir J 2007; 29: 737-744 Year: 2007
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension Source: Eur Respir J 2006; 28: 1190-1194 Year: 2006
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
The application of B-type natriuretic peptide level of the dyspneic patients ; differentiation between cor pulmonale and left ventricular dysfunction Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003
Plasma VEGF correlates with right ventricular function in pulmonary hypertension Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005
Prediction of right ventricular dysfunction in patients with pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 602s Year: 2007
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 1160-1166 Year: 2008
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Right heart dysfunction (RHD) in patients with acute pulmonary embolism (PE): correlation between distribution of clots, troponin I and prognosis Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010